Platypnoea-orthodeoxia syndrome after percutaneous treatment of ruptured sinus Valsalva complicated by SARS-Cov-2 pneumonia: a case report.

COVID-19 infection Case report Platypnoea–orthodeoxia syndrome Rupture of sinus of Valsalva

Journal

European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741

Informations de publication

Date de publication:
May 2021
Historique:
received: 03 11 2020
revised: 24 11 2020
accepted: 07 04 2021
entrez: 10 6 2021
pubmed: 11 6 2021
medline: 11 6 2021
Statut: epublish

Résumé

Rupture of sinus of Valsalva (RSV) to right atrium (RA) causes significant left to right shunt, tricuspid regurgitation, and right ventricular failure. If left uncorrected it can lead to biventricular heart failure. Hence, early invasive management is advised. To date, there is no report about platypnoea-orthodeoxia syndrome (POS) after device closure of ruptured sinus of Valsalva. A 50-year-old woman with dyspnoea of exertion and rupture of sinus valsalva to right atrium was referred to our hospital. On admission, chest computed tomography (CT) was normal. After closure of the rupture, she developed orthostatic hypoxemia and frequent cough. A repeat chest CT was suggestive of COVID-19 infection which most probably occurred during the hospitalization. Although COVID-19 was thought to be the only culprit, her symptoms were not solely justified by COVID-19. Transthoracic echocardiography showed patent foramen ovale (PFO) with significant shunt. PFO device closure was performed under intracardiac echocardiography guidance. Interatrial septum deformation may happen after RSV correction and right to left shunt from PFO may become more significant. POS is an important indication for PFO closure which should be noticed by careful examination. As COVID-19 is the most frequent pathology these days, it may delay other probable diagnosis, and hence detailed history taking and physical examination is mandatory.

Sections du résumé

BACKGROUND BACKGROUND
Rupture of sinus of Valsalva (RSV) to right atrium (RA) causes significant left to right shunt, tricuspid regurgitation, and right ventricular failure. If left uncorrected it can lead to biventricular heart failure. Hence, early invasive management is advised. To date, there is no report about platypnoea-orthodeoxia syndrome (POS) after device closure of ruptured sinus of Valsalva.
CASE SUMMARY METHODS
A 50-year-old woman with dyspnoea of exertion and rupture of sinus valsalva to right atrium was referred to our hospital. On admission, chest computed tomography (CT) was normal. After closure of the rupture, she developed orthostatic hypoxemia and frequent cough. A repeat chest CT was suggestive of COVID-19 infection which most probably occurred during the hospitalization. Although COVID-19 was thought to be the only culprit, her symptoms were not solely justified by COVID-19. Transthoracic echocardiography showed patent foramen ovale (PFO) with significant shunt. PFO device closure was performed under intracardiac echocardiography guidance.
DISCUSSION CONCLUSIONS
Interatrial septum deformation may happen after RSV correction and right to left shunt from PFO may become more significant. POS is an important indication for PFO closure which should be noticed by careful examination. As COVID-19 is the most frequent pathology these days, it may delay other probable diagnosis, and hence detailed history taking and physical examination is mandatory.

Identifiants

pubmed: 34109294
doi: 10.1093/ehjcr/ytab176
pii: ytab176
pmc: PMC8184264
doi:

Types de publication

Case Reports

Langues

eng

Pagination

ytab176

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Eur Rev Med Pharmacol Sci. 2014;18(18):2599-604
pubmed: 25317791
Case Rep Cardiol. 2016;2016:6954121
pubmed: 27610250
Neth Heart J. 2010 Apr;18(4):209-11
pubmed: 20428420
Asian Cardiovasc Thorac Ann. 2008 Oct;16(5):361-5
pubmed: 18812342
J Interv Cardiol. 2004 Feb;17(1):53-8
pubmed: 15009772
Tex Heart Inst J. 2003;30(2):152-4
pubmed: 12809262
J Clin Diagn Res. 2015 Aug;9(8):TD01-2
pubmed: 26468470
Am J Cardiol. 1975 Jun;35(6):918-22
pubmed: 1130293
Cardiovasc Intervent Radiol. 2005 Mar-Apr;28(2):164-8
pubmed: 15719178
Clin Cardiol. 2015 Mar;38(3):185-9
pubmed: 25757442
Eur Heart J. 2018 Aug 1;39(29):2695-2696
pubmed: 30289514
Respir Physiol Neurobiol. 2020 Nov;282:103515
pubmed: 32777268
Am J Cardiol. 2007 Apr 15;99(8):1159-64
pubmed: 17437748

Auteurs

Yaser Jenab (Y)

Interventional Cardiologist, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Ali Hosseinsabet (A)

Echocardiologist, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Laura Vaskelyte (L)

CardioVascular Center Frankfurt, Frankfurt, Germany.

Kaveh Hosseini (K)

Master of Public Health, Tehran Heart Center, Tehran University of Medical Sciences, North Kargar Ave., Tehran 1411713138, Iran.

Classifications MeSH